Studying treatment response in young people with brain tumors
Part of Cancer clinical trials.
This study looks at how young people with certain brain tumors respond to treatment. It aims to understand why some tumors resist therapy, which may help improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 15 and 39 years old.
- You have been diagnosed with a high-risk brain tumor, such as a glioma, medulloblastoma, or ependymoma.
- You are able to care for yourself (Karnofsky score of 60 or higher).
- You have had a biopsy or surgery that provided enough tumor tissue for testing.
- Your doctor plans to give you standard treatment (like surgery, radiation, or chemotherapy).
- You are expected to live at least 6 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This is an observational study that collects and compares information from patients with primary brain tumors and their treatment results. It uses stored tumor tissue and brain scans to better understand outcomes using updated tumor classification methods.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This study tests a personalized treatment plan for children and young adults whose medulloblastoma or ependymoma has come back. It aims to guide doctors using new tissue from surgery or biopsy after earlier treatments are fully finished.
This Phase 1/2 trial tests a study treatment for children and young adults under 22 whose brain glioma has come back or isn’t responding to prior treatment. It’s designed to see whether the treatment is safe and effective for shrinking tumors in this situation.
Hear when a new Glioma, Malignant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.